The company develops autologous cellular therapies for the treatment of sclerosis, rheumatoid arthritis, diabetes and heart failure.
http://reports.pr-inside.com/report-published-opexa-therapeutics-inc-r3752445.htm
http://reports.pr-inside.com/report-published-opexa-therapeutics-inc-r3752445.htm
No comments:
Post a Comment